606 related articles for article (PubMed ID: 24384771)
1. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
Matys U; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S
Adv Med Sci; 2013; 58(2):353-61. PubMed ID: 24384771
[TBL] [Abstract][Full Text] [Related]
2. Serum cystatin C and serum and urine NGAL in the kidney function assessment of patients with MGUS.
Stelmach-Goldys A; Czarkowska-Paczek B; Wyczalkowska-Tomasik A; Paczek L
Eur J Haematol; 2015 Feb; 94(2):162-8. PubMed ID: 25046079
[TBL] [Abstract][Full Text] [Related]
3. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.
Fu WJ; Li BL; Wang SB; Chen ML; Deng RT; Ye CQ; Liu L; Fang AJ; Xiong SL; Wen S; Tang HH; Chen ZX; Huang ZH; Peng LF; Zheng L; Wang Q
Diabetes Res Clin Pract; 2012 Jan; 95(1):105-9. PubMed ID: 22015481
[TBL] [Abstract][Full Text] [Related]
4. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Pawlak K; Dobrzycki S
Nephrology (Carlton); 2008 Apr; 13(2):153-6. PubMed ID: 18275504
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
[TBL] [Abstract][Full Text] [Related]
6. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
[TBL] [Abstract][Full Text] [Related]
7. Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease.
Malyszko J; Bachorzewska-Gajewska H; Poniatowski B; Malyszko JS; Dobrzycki S
Ren Fail; 2009; 31(10):910-9. PubMed ID: 20030526
[TBL] [Abstract][Full Text] [Related]
8. [Predict value of monitoring changes of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 after coronary angiography and percutaneous coronary intervention on early diagnosis of contrast-induced nephropathy].
Wang L; Pu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):301-4. PubMed ID: 24924456
[TBL] [Abstract][Full Text] [Related]
9. Tubular biomarkers to assess progression of diabetic nephropathy.
Tramonti G; Kanwar YS
Kidney Int; 2011 May; 79(10):1042-4. PubMed ID: 21527942
[TBL] [Abstract][Full Text] [Related]
10. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil Gelatinase--Associated Lipocalin and Cystatin C Are Sensitive Markers of Renal Injury in Patients With Multiple Myeloma.
Papassotiriou GP; Kastritis E; Gkotzamanidou M; Christoulas D; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Roussou M; Margeli A; Papassotiriou I; Dimopoulos MA; Terpos E
Clin Lymphoma Myeloma Leuk; 2016 Jan; 16(1):29-35. PubMed ID: 26632077
[TBL] [Abstract][Full Text] [Related]
12. Renal effects of coronary artery bypass graft surgery in diabetic and non-diabetic patients: a study with urinary neutrophil gelatinase-associated lipocalin and serum cystatin C.
Arun O; Celik G; Oc B; Unlu A; Celik JB; Oc M; Duman A
Kidney Blood Press Res; 2015; 40(2):141-52. PubMed ID: 25832128
[TBL] [Abstract][Full Text] [Related]
13. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue?
Pennemans V; Rigo JM; Faes C; Reynders C; Penders J; Swennen Q
Clin Chem Lab Med; 2013 Sep; 51(9):1795-802. PubMed ID: 23648635
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of renal function, which and when?
Wasung ME; Chawla LS; Madero M
Clin Chim Acta; 2015 Jan; 438():350-7. PubMed ID: 25195004
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
[TBL] [Abstract][Full Text] [Related]
16. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).
Peralta CA; Katz R; Bonventre JV; Sabbisetti V; Siscovick D; Sarnak M; Shlipak MG
Am J Kidney Dis; 2012 Dec; 60(6):904-11. PubMed ID: 22749388
[TBL] [Abstract][Full Text] [Related]
17. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
[TBL] [Abstract][Full Text] [Related]
18. Renal function after percutaneous coronary interventions depending on the type of hydration.
Jarocka IT; Bachórzewska-Gajewska H; Kobus G; Czaban S; Małyszko J; Dobrzycki S
Adv Med Sci; 2013; 58(2):369-75. PubMed ID: 24285128
[TBL] [Abstract][Full Text] [Related]
19. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.
Nielsen SE; Andersen S; Zdunek D; Hess G; Parving HH; Rossing P
Kidney Int; 2011 May; 79(10):1113-8. PubMed ID: 21270761
[TBL] [Abstract][Full Text] [Related]
20. Assessment of biochemical markers in the early post-burn period for predicting acute kidney injury and mortality in patients with major burn injury: comparison of serum creatinine, serum cystatin-C, plasma and urine neutrophil gelatinase-associated lipocalin.
Yang HT; Yim H; Cho YS; Kym D; Hur J; Kim JH; Chun W; Kim HS
Crit Care; 2014 Jul; 18(4):R151. PubMed ID: 25023056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
